Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization. (Q54293320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

title

Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

Nusret Akpolat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Mehmet K Kaya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

Tamer Demir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

Hakan Bulut

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

publication date

24 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

Clinical and Experimental Ophthalmology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

449-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

Corneal neovascularization

29 February 2020

cites work

1 reference

Ocular angiogenesis: the role of growth factors

21 January 2018

1 reference

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing

21 January 2018

1 reference

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis

21 January 2018

1 reference

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

Treatments for Corneal Neovascularization: A Review

21 January 2018

1 reference

Corneal neovascularization: an anti-VEGF therapy review

21 January 2018

1 reference

Corneal neovascularization: molecular events and therapeutic options.

21 January 2018

1 reference

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.

21 January 2018

1 reference

Therapy of breast cancer with molecular targeting agents.

21 January 2018

1 reference

Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas

21 January 2018

1 reference

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

21 January 2018

1 reference

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

21 January 2018

1 reference

Targeted therapy for breast cancer prevention

21 January 2018

1 reference

Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice

21 January 2018

1 reference

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

21 January 2018

1 reference

Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization

21 January 2018

1 reference

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer

21 January 2018

1 reference

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases

21 January 2018

1 reference

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma

21 January 2018

1 reference

Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis

21 January 2018

1 reference

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEO.12500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25640924 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference